Sponsor or institution
Clinical trials and research at Gan & Lee Pharmaceuticals.
As of November 12, 2026, Find a Trial lists 6 clinical trials run by Gan & Lee Pharmaceuticals. that are recruiting, in China. By phase: Phase 3 (4), Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| GZC8072 tablets: safety and how the body handles it after a single dose in healthy people and after multiple doses in people who are overweight or obese | Phase 1 | Beijing | Recruiting | Aug 25, 2026 |
| GZR33 Injection plus Insulin Degludec for Type 2 Diabetes in Need of More Control | Phase 3 | Beijing | Recruiting | Apr 14, 2026 |
| Comparing GZR4 versus insulin icodec for adults with type 2 diabetes on basal insulin | Phase 3 | Linyi, Shandong | Recruiting | Sep 10, 2025 |
| Comparing GZR18 injection versus semaglutide (Wegovy) for adults who are overweight or obese | Phase 3 | Beijing | Recruiting | Sep 2, 2025 |
| Pharmacokinetics and safety of GZR18 injection in adults with and without liver insufficiency | Phase 1 | Beijing | Recruiting | Aug 27, 2025 |
| Evaluating Bempedoic Acid for treating high cholesterol | Phase 3 | Beijing | Recruiting | Jan 17, 2025 |
All recruiting trials (6)
-
GZC8072 tablets: safety and how the body handles it after a single dose in healthy people and after multiple doses in people who are overweight or obese
This study tests GZC8072 tablets to see if they are safe and how they behave in the body after a single dose in healthy adults and after repeated doses in adults who are overweight or obese.
-
GZR33 Injection plus Insulin Degludec for Type 2 Diabetes in Need of More Control
This study tests whether daily GZR33 injection plus daily Insulin Degludec can help adults with type 2 diabetes who aren’t adequately controlled by pills.
-
Comparing GZR4 versus insulin icodec for adults with type 2 diabetes on basal insulin
This trial will test whether GZR4 works as well as and is as safe as insulin icodec for adults with type 2 diabetes who are being treated with basal insulin.
-
Comparing GZR18 injection versus semaglutide (Wegovy) for adults who are overweight or obese
This compares GZR18 injection to semaglutide (Wegovy) to see if GZR18 helps adults who are overweight or obese lose weight and is safe.
-
Pharmacokinetics and safety of GZR18 injection in adults with and without liver insufficiency
This will test a single dose of GZR18 injection to see how the drug is processed and whether it is safe in adults with normal liver function and in adults with mild, moderate, or severe liver insufficiency.
-
Evaluating Bempedoic Acid for treating high cholesterol
This study is testing if Bempedoic Acid can help people with high cholesterol who haven't had enough success with statins to lower their cholesterol levels better.
Quick answers
How many clinical trials run by Gan & Lee Pharmaceuticals. are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 4, Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.